DCF — OCHSNER CLINIC FOUNDATION
Enterprise Value: $-4.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-4.3B
Enterprise Value
$-1.3B
PV of Cash Flows
$-2.9B
PV of Terminal Value
$-4.7B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.1B | $-276.0M | -13.0% | $-364.1M | $-331.0M |
| Year 2 | $2.1B | $-262.9M | -12.0% | $-353.6M | $-292.2M |
| Year 3 | $2.2B | $-248.7M | -11.0% | $-342.1M | $-257.0M |
| Year 4 | $2.3B | $-244.8M | -11.0% | $-341.0M | $-232.9M |
| Year 5 | $2.3B | $-246.3M | -11.0% | $-345.4M | $-214.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-4.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13767880009283795
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5